FeverText: Assessing Fever Rates After Influenza and Pneumococcal Vaccination During the 2011-12 Influenza Season Using Text Messaging

Trial Profile

FeverText: Assessing Fever Rates After Influenza and Pneumococcal Vaccination During the 2011-12 Influenza Season Using Text Messaging

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jul 2012

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Influenza virus infections; Pneumococcal infections
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
    • 31 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Nov 2011 Actual initiation date (November 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top